Search Prime Grants

R35CA263815

Project Grant

Overview

Grant Description
Biology and Function of Exosomes in Cancer - Abstract

Trillions of exosomes, a subset of extracellular vesicles, are naturally present in the blood and tissue, and all cells secrete them into the extracellular milieu. Exosomes are on average around 100 nm in diameter and are speculated to have an endosomal origin, with a membrane lipid bilayer of similar orientation as the plasma membrane of the cells they originate from, and with capacity to enter other cells to deliver their constituents.

The cargo exosomes include proteins, lipids, mRNA, non-coding RNAs (ncRNAs), microRNAs (miRNAs), and genomic DNA; and their production and content can vary depending on the cellular source. Exosomes may represent a novel means of intercellular communication, but their biogenesis, trafficking, organ tropism, and impact on normal physiology and pathology in the in vivo setting is largely unknown.

Similarly, the function of exosomes in pancreatic cancer remains understudied. Our research program is currently designed to address key unanswered scientific questions related to the basic biology of exosomes, their functional role in pathogenesis and therapeutic intervention of pancreatic cancer, a disease with dismal prognosis, and on the rise in the United States.

Employing newly engineered mice, we propose to address the role of exosomes in the complex interplay between cancer cells and the cells of the tumor microenvironment. Additionally, employing our established platform for clinical-grade exosomes production, we will investigate the potential of engineered exosomes to target driver oncogenes and modulate the pancreatic cancer immune microenvironment/tumor immunity to facilitate therapeutic response.

The proposed focus areas are rooted in the expertise we have developed within our research program over the last decade, and our track record provides the rationale and guidance for a higher chance of feasibility of the proposed studies, with potential for translational application.
Funding Goals
TO PROVIDE FUNDAMENTAL INFORMATION ON THE CAUSE AND NATURE OF CANCER IN PEOPLE, WITH THE EXPECTATION THAT THIS WILL RESULT IN BETTER METHODS OF PREVENTION, DETECTION AND DIAGNOSIS, AND TREATMENT OF NEOPLASTIC DISEASES. CANCER BIOLOGY RESEARCH INCLUDES THE FOLLOWING RESEARCH PROGRAMS: CANCER CELL BIOLOGY, CANCER IMMUNOLOGY, HEMATOLOGY AND ETIOLOGY, DNA AND CHROMOSOMAL ABERRATIONS, TUMOR BIOLOGY AND METASTASIS, AND STRUCTURAL BIOLOGY AND MOLECULAR APPLICATIONS.
Grant Program (CFDA)
Place of Performance
Houston, Texas 770304009 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 519% from $546,882 to $3,385,880.
The Univeristy Of Texas M.D. Anderson Cancer Center was awarded Exosome Function in Pancreatic Cancer: A Study Project Grant R35CA263815 worth $3,385,880 from National Cancer Institute in September 2022 with work to be completed primarily in Houston Texas United States. The grant has a duration of 7 years and was awarded through assistance program 93.396 Cancer Biology Research. The Project Grant was awarded through grant opportunity NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 8/20/25

Period of Performance
9/1/22
Start Date
8/31/29
End Date
42.0% Complete

Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R35CA263815

Transaction History

Modifications to R35CA263815

Additional Detail

Award ID FAIN
R35CA263815
SAI Number
R35CA263815-998911919
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
S3GMKS8ELA16
Awardee CAGE
0KD38
Performance District
TX-09
Senators
John Cornyn
Ted Cruz

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $1,499,441 100%
Modified: 8/20/25